SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 17, 2026

ANIX

Anixa Biosciences Inc
BULLISH
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $60K total
Actionable Insight ▲ Bullish

The CEO's purchase adds credibility to management's conviction, but the small dollar amount limits the signal. Monitor for additional insider buying or upcoming catalysts (e.g., clinical trial updates).

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
ANIX ▲ +2.60% at T+60d
LONG call ✓ call won +2.60% · α vs SPY -0.55% · entry $2.69 → $2.76
Entry anchored
Jun 17, 11:20 AM ET
via exchange tick
T+1d
+8.18%
call +8.18% · α +7.40%
$2.91
settled 4mo ago
T+5d
+1.86%
call +1.86% · α +2.90%
$2.74
settled 4mo ago
T+20d
+23.42%
call +23.42% · α +22.10%
$3.32
settled 3mo ago
T+60d
+2.60%
call +2.60% · α -0.55%
$2.76
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two Anixa insiders, including CEO Amit Kumar, made open-market purchases totaling ~$60K over a 5-day window. While the dollar amount is small relative to the $89M market cap (0.07%), the cluster of buys—especially by the CEO—carries modest positive signal per insider-trading literature.

Key Financial Metrics

Direction
buying
Total Value
$60.0K
Insiders
2

Key Facts

  • CEO Amit Kumar purchased 21,000 shares at $2.50 for $52,500 on June 12, 2026.
  • Director Lewis H. Titterton Jr. purchased 2,836 shares at $2.64 for $7,487 on June 16, 2026.
  • Total insider buying in the cluster is ~$60K, representing 0.07% of market cap.
  • Both transactions are open-market purchases (code P), not grants or exercises.

Financial Impact

Insider purchases total ~$60K, a trivial fraction of market cap but notable as a cluster of open-market buys.

insider ownership

Risk Factors

  • Insider buying is small relative to market cap; may be routine portfolio rebalancing.
  • Micro-cap biotech stocks are highly volatile and subject to binary clinical outcomes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIX-1781709709805
3 reports for ANIX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ANIX — sortable, filterable
TypeNow
Sep 30, 2026
25d ago
Insider Cluster
BULLISH ★ 5/10
$2.93 $2.95▲ +0.68%▼ −1.23%$2.99 (+2.05%)
Sep 28, 2026
27d ago
Insider Cluster
BULLISH ★ 4/10
$2.79 $2.95▲ +5.73%▲ +4.53%$2.99 (+7.17%)
Jun 17, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.69 $2.74▲ +1.86%▲ +2.90%$2.99 (+11.15%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 1h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026